HEPA Archived Articles
Hepion Pharmaceuticals (NASDAQ:HEPA): Navigating the Challenges of the Liver Disease Landscape
Published on March 13, 2025
Hepion Pharmaceuticals (NASDAQ:HEPA): Navigating the Challenges of Drug Development and Pursuing Strategic Opportunities
Published on November 30, 2024
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA): Navigating the Challenges of Liver Disease Drug Development
Published on September 24, 2024